Number of times cited according to CrossRef:

Robert McCutcheon, Stephen J. Kaar, Oliver D. Howes, Drugs to Treat Schizophrenia and Psychosis (Dopamine Antagonists and Partial Agonists Other Than Clozapine), Seminars in Clinical Psychopharmacology, 10.1017/9781911623465, (290-325),

Michael D. Coleman, Cytochrome P450 Inhibition, Human Drug Metabolism, 10.1002/9781119658016, (183-261),

Sahil Munjal, Paula C. Zimbrean, Psychiatric Aspects of Wilson Disease, Management of Wilson Disease, 10.1007/978-3-319-91527-2_7, (121-142),

Tomasz Litwin, Petr Dusek, Tomasz Szafrański, Karolina Dzieżyc, Anna Członkowska, Janusz K. Rybakowski, Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment, Therapeutic Advances in Psychopharmacology, 10.1177/2045125318759461, 8, 7, (199-211),

Gordana Nikolić, Nikola M. Stojanović, Pavle J. Randjelović, Snežana Manojlović, Niko S. Radulović, An epidemiological study on herbal product self-medication practice among psychotic outpatients from Serbia: A cross-sectional study, Saudi Pharmaceutical Journal, 10.1016/j.jsps.2018.01.009, 26, 3, (335-341),

Anna Członkowska, Tomasz Litwin, Petr Dusek, Peter Ferenci, Svetlana Lutsenko, Valentina Medici, Janusz K. Rybakowski, Karl Heinz Weiss, Michael L. Schilsky, Wilson disease, Nature Reviews Disease Primers, 10.1038/s41572-018-0018-3, 4, 1,

Peggy Bosch, Sabina Lim, Heike Staudte, Sujung Yeo, Sook-Hyun Lee, Pia Barisch, Benoît Perriard, Maurits Van den Noort, Pharmacological Treatment for Long-Term Patients with Schizophrenia and Its Effects on Sleep in Daily Clinical Practice: A Pilot Study, Medicines, 10.3390/medicines5020044, 5, 2, (44),

Janet Sultana, Francesco Giorgianni, Federico Rea, Ersilia Lucenteforte, Niccolò Lombardi, Alessandro Mugelli, Alfredo Vannacci, Rosa Liperoti, Ursula Kirchmayer, Cristiana Vitale, Alessandro Chinellato, Giuseppe Roberto, Giovanni Corrao, Gianluca Trifirò, All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: a multi-center retrospective cohort study in Italy, Expert Opinion on Drug Metabolism & Toxicology, 10.1080/17425255.2019.1561860, (1-10),

Heeyoung Lee, Britney B. Scolieri, Prabir K. Mullick, Learned lessons from patients who take clozapine: A case study, Perspectives in Psychiatric Care, 10.1111/ppc.12245, 54, 4, (457-461),

Svetlana Azova, Timothy Rice, Blanca Garcia-Delgar, Barbara J. Coffey, New-Onset Psychosis in an Adolescent with Wilson's Disease, Journal of Child and Adolescent Psychopharmacology, 10.1089/cap.2016.29106.bjc, 26, 3, (301-304),

Ruki Wijesinghe, A review of pharmacokinetic and pharmacodynamic interactions with antipsychotics, Mental Health Clinician, 10.9740/mhc.2016.01.021, 6, 1, (21-27),

Ilia Bountouni, Panagiotis Zis, K. Ray Chaudhuri, Anette Schrag, Psychosis in Parkinson’s Disease, Neuropsychiatric Symptoms of Movement Disorders, 10.1007/978-3-319-09537-0_6, (113-139),

Yasuhisa Nagasaka, Tomokazu Sano, Kazuo Oda, Akio Kawamura, Takashi Usui, Impact of genetic deficiencies of P-glycoprotein and breast cancer resistance protein on pharmacokinetics of aripiprazole and dehydroaripiprazole, Xenobiotica, 10.3109/00498254.2014.901585, 44, 10, (926-932),

L. Renata Thronson, Genevieve L. Pagalilauan, Psychopharmacology, Medical Clinics of North America, 10.1016/j.mcna.2014.06.001, 98, 5, (927-958),